Literature DB >> 2841495

Long terminal repeat (LTR) sequences, env, and a region near the 5' LTR influence the pathogenic potential of recombinants between Rous-associated virus types 0 and 1.

D W Brown1, B P Blais, H L Robinson.   

Abstract

A series of recombinants between Rous-associated virus type 0 (RAV-0), RAV-1, and a replication-competent avian leukosis virus vector (RCAN) have been tested for disease potential in day-old inoculated K28 chicks. RAV-0 is a benign virus, whereas RAV-1 and RCAN induce lymphoma and a low incidence of a variety of other neoplasms. The results of the oncogenicity tests indicate that (i) the long terminal repeat regions of RAV-1 and RCAN play a major role in disease potential, (ii) subgroup A envelope glycoproteins are associated with a two- to fourfold higher incidence of lymphoma than subgroup E glycoproteins, and (iii) certain combinations of 5' viral and env sequences cause osteopetrosis in a highly context-dependent manner. Long terminal repeat and env sequences appeared to influence lymphomogenic potential by determining the extent of bursal infection within the first 2 to 3 weeks of life. This would suggest that bursal but not postbursal stem cells are targets for avian leukosis virus-induced lymphomogenesis. The induction of neutralizing antibody had no obvious influence on the incidence of lymphoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841495      PMCID: PMC253467          DOI: 10.1128/JVI.62.9.3431-3437.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  An avian leukosis virus associated with stocks of Rous sarcoma virus.

Authors:  H RUBIN; P K VOGT
Journal:  Virology       Date:  1962-05       Impact factor: 3.616

2.  Expression of endogenous ALV antigens and susceptibility to subgroup E ALV in three strains of chickens (endogenous avian C-type virus).

Authors:  H L Robinson; W F Lamoreux
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

3.  Low oncogenic potential of avian endogenous RNA tumor virus infection or expression.

Authors:  J V Motta; L B Crittenden; H G Purchase; H A Stone; R L Witter
Journal:  J Natl Cancer Inst       Date:  1975-09       Impact factor: 13.506

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  The oncogenic effects of nontransforming viruses from avian myeloblastosis virus.

Authors:  R E Smith; C Moscovici
Journal:  Cancer Res       Date:  1969-07       Impact factor: 12.701

6.  Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions.

Authors:  K Toyoshima; P K Vogt
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

7.  Patterns of viral interference in the avian leukosis and sarcoma complex.

Authors:  P K Vogt; R Ishizaki
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

8.  Kinetic differences in unresponsiveness of thymus and bone marrow cells.

Authors:  J M Chiller; G S Habicht; W O Weigle
Journal:  Science       Date:  1971-02-26       Impact factor: 47.728

9.  Bursal and postbursal stem cells in chicken. Functional characteristics.

Authors:  P Toivanen; A Toivanen
Journal:  Eur J Immunol       Date:  1973-09       Impact factor: 5.532

10.  Oncogenicity of avian leukosis viruses of different subgroups and of mutants of sarcoma viruses.

Authors:  H G Purchase; W Okazaki; P K Vogt; H Hanafusa; B R Burmester; L B Crittenden
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

View more
  18 in total

1.  The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease.

Authors:  J L Portis; S Perryman; F J McAtee
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque.

Authors:  V Courgnaud; F Lauré; P N Fultz; L Montagnier; C Bréchot; P Sonigo
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Cytocidal effect caused by the envelope glycoprotein of a newly isolated avian hemangioma-inducing retrovirus.

Authors:  N Resnick-Roguel; H Burstein; J Hamburger; A Panet; A Eldor; I Vlodavsky; M Kotler
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses.

Authors:  C A Holland; C Y Thomas; S K Chattopadhyay; C Koehne; P V O'Donnell
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Tissue-specific lability and expression of avian leukosis virus long terminal repeat enhancer-binding proteins.

Authors:  A Ruddell; M L Linial; M Groudine
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

6.  Virological events leading to spontaneous AKR thymomas.

Authors:  J P Stoye; C Moroni; J M Coffin
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Replication-competent retroviral vectors encoding alkaline phosphatase reveal spatial restriction of viral gene expression/transduction in the chick embryo.

Authors:  D M Fekete; C L Cepko
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

8.  Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant.

Authors:  F J Novembre; P R Johnson; M G Lewis; D C Anderson; S Klumpp; H M McClure; V M Hirsch
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  a1/EBP: a leucine zipper protein that binds CCAAT/enhancer elements in the avian leukosis virus long terminal repeat enhancer.

Authors:  W J Bowers; A Ruddell
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Transformation of chicken myelomonocytic cells by a retrovirus expressing the v-myb oncogene from the long terminal repeats of avian myeloblastosis virus but not Rous sarcoma virus.

Authors:  R D Press; A Kim; D L Ewert; E P Reddy
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.